ChromaDex Corporation
NASDAQ:CDXC
7.01 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | ChromaDex Corporation |
Symbool | CDXC |
Munteenheid | USD |
Prijs | 7.01 |
Beurswaarde | 535,446,933 |
Dividendpercentage | 0% |
52-weken bereik | 1.32 - 7.58 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Robert N. Fried |
Website | https://www.chromadex.com |
An error occurred while fetching data.
Over ChromaDex Corporation
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)